Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MDR LIMITED (NXNR)

  • SEC News
  • April 30, 2026, 11:08 UTC
  • 2
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") Per Share

Comment Full text

YANGZIJIANG MARITIME DEVELOPMENT LTD. (8YZ)

  • SEC News
  • April 30, 2026, 11:07 UTC
  • 0
  • 0 comments

Change - Announcement of Cessation: Retirement of Independent Non-Executive Director

Comment Full text

VISTANCE NETWORKS, INC. (VISN)

  • SEC News
  • April 30, 2026, 11:07 UTC
  • 0
  • 1 comments

(25% Negative) VISTANCE NETWORKS, INC. (VISN) Reports Q2 2026 Financial Results

Comment Full text

UNIQURE N.V. (QURE)

  • SEC News
  • April 30, 2026, 11:07 UTC
  • 0
  • 1 comments

(90% Positive) UNIQURE N.V. (QURE) Provides Update on granted for AMT-130 in Huntington’s disease

Comment Full text

DIEBOLD NIXDORF, INC (DBD)

  • SEC News
  • April 30, 2026, 11:06 UTC
  • 0
  • 1 comments

(70% Positive) DIEBOLD NIXDORF, INC (DBD) Reports Q2 2026 Financial Results

Comment Full text

WAYFAIR INC. (W)

  • SEC News
  • April 30, 2026, 11:06 UTC
  • 0
  • 1 comments

(30% Negative) WAYFAIR INC. (W) Reports Q2 2026 Financial Results

Comment Full text

HILTON GRAND VACATIONS INC. (HGV)

  • SEC News
  • April 30, 2026, 11:06 UTC
  • 0
  • 1 comments

(30% Negative) HILTON GRAND VACATIONS INC. (HGV) Reports Q2 2026 Financial Results

Comment Full text

CROCS, INC. (CROX)

  • SEC News
  • April 30, 2026, 11:06 UTC
  • 0
  • 1 comments

(30% Negative) CROCS, INC. (CROX) Reports Q2 2026 Financial Results

Comment Full text

ATA CREATIVITY GLOBAL (AACG)

  • SEC News
  • April 30, 2026, 11:05 UTC
  • 0
  • 1 comments

Director Ma Kevin Xiaofeng 🟢 acquired 1.2M shares of ATA Creativity Global (AACG) Transaction Date: Apr 30, 2026 | Filing ID: 052109

Comment Full text

ASPIAL CORPORATION LIMITED (A30)

  • SEC News
  • April 30, 2026, 11:05 UTC
  • 0
  • 0 comments

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy Back

Comment Full text
  • Previous
  • 1000
  • 1001
  • 1002
  • 1003
  • 1004
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(268197)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156238)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin